Christopher Abbott
Net worth: 17 M $ as of 30/03/2024
Profile
Christopher M.
Abbott was the Chairman-Emeritus and founder of Genetic Signatures Ltd.
Dr. Abbott is also the founder of Peplin Ltd., Maple-Brown Abbott Ltd.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GENETIC SIGNATURES LTD.
20.59% | 27/08/2023 | 38,392,200 ( 20.59% ) | 17 M $ | 30/03/2024 |
Former positions of Christopher Abbott
| Companies | Position | End |
|---|---|---|
Maple-Brown Abbott Ltd.
 Maple-Brown Abbott Ltd. Investment ManagersFinance Maple-Brown Abbott Ltd. (MBA) is an investment management firm headquartered in Sydney, Australia. The firm was founded by Robert Maple-Brown and Chris Abbott in 1984. They are a subsidiary of Maple-Brown Family Investments Pty Ltd. The firm offers Australian managed investment schemes, UCITS (Undertaking for Collective Investment in Transferable Securities) funds in a variety of currencies and discrete mandates to clients around the world. Their clients include superannuation funds, financial institutions, endowments, charities, family offices, financial advisers, wholesale investors and retail investors. MBA is a socially responsible investor and a signatory to the UN Principles for Responsible Investment (UNPRI). | Founder | - |
Peplin Ltd.
 Peplin Ltd. Pharmaceuticals: OtherHealth Technology Peplin Ltd. provides development and commercialisation of prescription human therapeutic products for the treatment of cancer. It also provides drug development process, clinical development and pre-clinical development services. It was was founded in 1998 and is located in Newstead, Australia | Founder | - |
| GENETIC SIGNATURES LIMITED | Founder | - |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| GENETIC SIGNATURES LIMITED | Commercial Services |
| Private companies | 2 |
|---|---|
Peplin Ltd.
Peplin Ltd. Pharmaceuticals: OtherHealth Technology Peplin Ltd. provides development and commercialisation of prescription human therapeutic products for the treatment of cancer. It also provides drug development process, clinical development and pre-clinical development services. It was was founded in 1998 and is located in Newstead, Australia | Health Technology |
Maple-Brown Abbott Ltd.
Maple-Brown Abbott Ltd. Investment ManagersFinance Maple-Brown Abbott Ltd. (MBA) is an investment management firm headquartered in Sydney, Australia. The firm was founded by Robert Maple-Brown and Chris Abbott in 1984. They are a subsidiary of Maple-Brown Family Investments Pty Ltd. The firm offers Australian managed investment schemes, UCITS (Undertaking for Collective Investment in Transferable Securities) funds in a variety of currencies and discrete mandates to clients around the world. Their clients include superannuation funds, financial institutions, endowments, charities, family offices, financial advisers, wholesale investors and retail investors. MBA is a socially responsible investor and a signatory to the UN Principles for Responsible Investment (UNPRI). | Finance |
- Stock Market
- Insiders
- Christopher Abbott
